Continuous Positive Airway Pressure (CPAP)

Continuous Positive Airway Pressure (CPAP) Market Research Report: Forecast (2022-2027)

By End Users (Hospitals and Clinics, Nursing Homes, Elderly Care Centers, Home-Use), By Type of Disorder (Obstructive Sleep Apnea (OSA), Chronic Obstructive Respiratory Disorder, Neuromuscular Disorde Read more

  • Healthcare
  • Sep 2022
  • 183
  • HC10249

Market Definition

A Continuous Positive Airway Pressure (CPAP) is a medical device that operates on spontaneous ventilation & gas exchange. The device compressor generates an uninterrupted stream of pressurized air across the air passage, improving oxygenated airflow via tube & mask. CPAP are often intended for people dealing with sleep-related breathing disorders, including obstructive sleep apnea (OSA), to keep their airways clear during sleep.

The device is also beneficial in treating preterm infants having underdeveloped lungs. CPAP is also known for maintaining a Positive End-Expiratory Pressure (PEEP), increasing the surface area of the alveolus, decreasing atelectasis, improving V/Q (Ventilation/Perfusion) matching, & enhancing oxygenation, among others.

Market Insights

The Global Continuous Positive Airway Pressure (CPAP) Market is projected to grow at a CAGR of around 7.70% during the forecast period, i.e., 2022-27. The market is driven by the rapidly increasing economic burden & challenges faced by the healthcare industry, especially after the advent of Covid-19, demonstrating a flooding number of patients with a high prevalence of respiratory diseases. It has paved the way for the broader adoption of devices like CPAP devices to address their conditions across healthcare settings. With the massive influx of patients globally & the high demand for CPAP, leading players are witnessing a presentation of growth opportunities to increase their production & distribution capacities and cater to the burgeoning requirements across different healthcare facilities globally. 

Report Coverage Details
Study Period Historical Data: 2017-20
Base Year: 2021
Forecast Period: 2022-27
CAGR (2022-2027) 7.70%
Regions Covered North America: The US, Canada
Europe: Germany, The UK, France, Italy, Spain
Asia-Pacific: China, Japan, India, South Korea
South America: Brazil
Middle East & Africa: UAE, South Africa, Saudi Arabia
Key Companies Profiled Apex Medical Corp., Airon Corporation, Asahi Kasei Corporation, BMC Medical Co., Ltd, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Koninklijke Philips N.V., Löwenstein Medical GmbH & Co. KG, Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC, Medtronic Plc, ResMed Inc., Smiths Group plc (Smiths Medical), Vyaire Medical, Inc.
Unit Denominations USD Million/Billion

 

Besides, an alarming rise in sleep apnea patients, especially across countries like the US, Canada, and others, is demonstrating a dire need for more CPAP devices. In the same line, people with chronic disorders like obesity & hypertension are more susceptible to developing obstructive sleep apnea, thereby passively influencing the demand for Continuous Positive Airway Pressure (CPAP) devices and stimulating the market. 

  • According to the World Health Organization (WHO), Sleep apnea accounts for nearly one billion of the global burden of sleeping disorders. Sleep apnea, being common in adults & older individuals, is said to have infected 1 to 6% of adults.
  • According to a report published by The Global Impact of Respiratory Disease, 24% of men aged 30–60 had obstructive sleep apnea.

Moreover, the continuous technological advancements in CPAP Devices, like Auto-adjusting devices that regulate the air pressure automatically, resulting in lesser assistance & enhanced comfort, further amplify the market growth. Such a substantial market ascension lies in the capability of these devices to store vast data, leading to improved clinical outcomes with minimal human errors by healthcare professionals.

Market Segmentation

Based on End Users:

  • Hospitals & Clinics
  • Nursing Homes
  • Elderly Care Centers
  • Home-Use

Among all, Hospitals & Clinics acquired a considerable share in the Global Continuous Positive Airway Pressure (CPAP) Market in recent years and are anticipated to prevail in the same trend during the forecast period. This growth attributes to a swift rise in the geriatric population, propelling emergency & long-term hospitalization requirements, demonstrating an escalation in the need for CPAP devices.

Likewise, the high birth rates, alongside the number of premature or newborn infants encountering undergrown lungs or indicating respiratory issues, are the other consumers of CPAP devices, instigating healthcare facilities like hospitals & clinics to stock such devices. As a result, the market is hinting toward the presence of lucrative opportunities for the leading players across the sector, stimulating the overall market trajectory through 2027. 

  • According to the American Academy of Sleep Medicine (AASM), consistent adherence to CPAP reduces the risk of 30-day hospital readmission among the geriatric population with comorbid obstructive sleep apnea & cardiovascular disease.

Based on Type of Disorder:

  • Obstructive Sleep Apnea (OSA)
  • Chronic Obstructive Respiratory Disorder
  • Neuromuscular Disorder
  • Asthma

Here, Obstructive Sleep Apnea (OSA) is anticipated to dominate the Global Continuous Positive Airway Pressure (CPAP) Market with the largest share during the forecast period. This dominance attributes to the wide adoption of CPAP devices used for treating Sleep Apnea and eliminating snoring. The doctors for such patients may recommend using a CPAP device. Backed by the growing prevalence of these health disorders, the market is set to witness an upswing in need & generate lucrative opportunities for the leading players to increase their production & distribution capacities to cater to the burgeoning demands globally.

  • According to research by the American Academy of Sleep Medicine, nearly 30 million adults in the U.S. have obstructive sleep apnea, a chronic disease that involves the frequent collapse of the upper airway during sleep and is said to be found in 40%-60% of people diagnosed with cardiovascular disease.

With the growing prevalence of OSA and spreading awareness among people about this syndrome, demonstrating frequent pauses in breathing during sleep accompanied by loud snoring, with the potential to cause critical health conditions, are playing a prominent role in augmenting the demand for CPAPs. Since such disorders require suitable & immediate treatment, the market shall observe an upsurge in demand during the forecast years.

  1. Market Segmentation
  2. Introduction
    1. Research Process
    2. Assumption
    3. Market Definition
  3. Executive Summary
  4. Impact of COVID-19 on Continuous Positive Airway Pressure (CPAP) Market
  5. Global Continuous Positive Airway Pressure (CPAP) Market Trends & Insights
  6. Global Continuous Positive Airway Pressure (CPAP) Market Regulations & Policy
    1. Associated Global Industry Bodies & Their Functions
    2. Regulations for Medical Devices
  7.  Global Continuous Positive Airway Pressure (CPAP) Market Intellectual Property Rights Analysis
    1. Quarterly Patent Analysis
    2. Country wise Patents
  8. Global Continuous Positive Airway Pressure (CPAP) Market Dynamics
    1. Growth Drivers
    2. Challenges
  9. Global Continuous Positive Airway Pressure (CPAP) Market Hotspot and Opportunities
  10. Global Epidemiological Developments in Reference to Continuous Positive Airway Pressure (CPAP): Region Wise Prevalence & Incidence 2017-2027
    1. North America
      1. Obstructive Sleep Apnea (OSA)
      2. Chronic Obstructive Respiratory Disorder
      3. Neuromuscular Disorder
      4. Asthma
    2. South America
      1. Obstructive Sleep Apnea (OSA)
      2. Chronic Obstructive Respiratory Disorder
      3. Neuromuscular Disorder
      4. Asthma
    3. Europe
      1. Obstructive Sleep Apnea (OSA)
      2. Chronic Obstructive Respiratory Disorder
      3. Neuromuscular Disorder
      4. Asthma
    4. Middle East & Africa
      1. Obstructive Sleep Apnea (OSA)
      2. Chronic Obstructive Respiratory Disorder
      3. Neuromuscular Disorder
      4. Asthma
    5. Asia-Pacific
      1. Obstructive Sleep Apnea (OSA)
      2. Chronic Obstructive Respiratory Disorder
      3. Neuromuscular Disorder
      4. Asthma
  11. Global Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
        1. Hospitals & Clinics
        2. Nursing Homes
        3. Elderly Care Centers
        4. Home-Use
      2. By Type of Disorder
        1. Obstructive Sleep Apnea (OSA)
        2. Chronic Obstructive Respiratory Disorder
        3. Neuromuscular Disorder
        4. Asthma
        5. Others
      3. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
      4. By Company
        1. Competition Matrix
        2. Market Share & Analysis
  12. North America Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
      2. By Type of Disorder
      3. By Company
    3. The US Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    4. Canada Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
  13. South America Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
      2. By Type of Disorder
      3. By Company
    3. Brazil Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
  14. Europe Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
      2. By Type of Disorder
      3. By Company
    3. Germany Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    4. The UK Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    5. France Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    6. Spain Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    7. Italy Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
  15. Middle East & Africa Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
      2. By Type of Disorder
      3. By Company
    3. Saudi Arabia Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    4. UAE Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    5. South Africa Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
  16. Asia Pacific Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
    1. Market Size & Analysis
      1. By Revenues in USD Million
      2. By Units Sold
    2. Market Share & Analysis
      1. By End Users
      2. By Type of Disorder
      3. By Company
    3. China Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    4. Japan Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    5. India Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
    6. South Korea Continuous Positive Airway Pressure (CPAP) Market Outlook, 2017- 2027F
      1. Market Size & Analysis
        1. By Revenues in USD Million
        2. By Units Sold
      2. Market Share & Analysis
        1. By End Users
  17. Competition Outlook
    1. Competition Matrix
      1. Brand Specialization
      2. Target Markets
      3. Target End-Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles
      1. Apex Medical Corp.
      2.  Airon Corporation  
      3. Asahi Kasei Corporation  
      4. BMC Medical Co., Ltd  
      5. Drägerwerk AG & Co. KGaA  
      6. Fisher & Paykel Healthcare Limited  
      7. General Electric Company  
      8. Getinge AB  
      9. Koninklijke Philips N.V.
      10. Löwenstein Medical GmbH & Co. KG  
      11. Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC  
      12. Medtronic Plc 
      13. ResMed Inc.
      14. Smiths Group plc (Smiths Medical)   
      15. Vyaire Medical, Inc.
  18. Disclaimer
Continuous Positive Airway Pressure (CPAP) Market - Segmentation slide
*This field is required